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Abstract
Introduction: The relative resistance of non-chondrodystrophic (NCD) canines to degenerative disc disease (DDD)
may be due to a combination of anabolic and anti-catabolic factors secreted by notochordal cells within the
intervertebral disc (IVD) nucleus pulposus (NP). Factors known to induce DDD include interleukin-1 beta (IL-1ß)
and/or Fas-Ligand (Fas-L). Therefore we evaluated the ability of notochordal cell conditioned medium (NCCM) to
protect NP cells from IL-1ß and IL-1ß +FasL-mediated cell death and degeneration.
Methods: We cultured bovine NP cells with IL-1ß or IL-1ß+FasL under hypoxic serum-free conditions (3.5% O2)
and treated the cells with either serum-free NCCM or basal medium (Advanced DMEM/F-12). We used flow
cytometry to evaluate cell death and real-time (RT-)PCR to determine the gene expression of aggrecan, collagen 2,
and link protein, mediators of matrix degradation ADAMTS-4 and MMP3, the matrix protection molecule TIMP1, the
cluster of differentiation (CD)44 receptor, the inflammatory cytokine IL-6 and Ank. We then determined the
expression of specific apoptotic pathways in bovine NP cells by characterizing the expression of activated caspases-
3, -8 and -9 in the presence of IL-1ß+FasL when cultured with NCCM, conditioned medium obtained using bovine
NP cells (BCCM), and basal medium all supplemented with 2% FBS.
Results: NCCM inhibits bovine NP cell death and apoptosis via suppression of activated caspase-9 and caspase-3/7.
Furthermore, NCCM protects NP cells from the degradative effects of IL-1ß and IL-1ß+Fas-L by up-regulating the
expression of anabolic/matrix protective genes (aggrecan, collagen type 2, CD44, link protein and TIMP-1) and
down-regulating matrix degrading genes such as MMP-3. Expression of ADAMTS-4, which encodes a protein for
aggrecan remodeling, is increased. NCCM also protects against IL-1+FasL-mediated down-regulation of Ank
expression. Furthermore, NP cells treated with NCCM in the presence of IL-1ß+Fas-L down-regulate the expression
of IL-6 by almost 50%. BCCM does not mediate cell death/apoptosis in target bovine NP cells.
Conclusions: Notochordal cell-secreted factors suppress NP cell death by inhibition of activated caspase-9 and -3/7
activity and by up-regulating genes contributing anabolic activity and matrix protection of the IVD NP. Harnessing
the restorative powers of the notochordal cell could lead to novel cellular and molecular strategies in the
treatment of DDD.
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Degenerative disc disease (DDD) is an extremely com-
mon and costly healthcare condition for which there is
no curative strategy [1]. Given the lack of a biological
strategy for regeneration of the degenerating disc, a
therapeutic intervention that may offer restorative quali-
ties to the disc is a much needed and widely sought
goal. The ideal biological agent might reactivate homeo-
static mechanisms innately inherent to the healthy inter-
vertebral disc (IVD). The capacity to re-establish
equilibrium between catabolic and anabolic tissue remo-
deling would represent the ideal regenerative strategy
for the treatment of DDD.
With respect to potential biological therapies, lessons
learned from the study of the non-chondrodystrophic
canine (NCD canine) IVD might provide essential mole-
cular clues for restoration of homeostasis to the disc.
T h eN C Dc a n i n ei su n i q u ea m o n gt h ec a n i n es u b - s p e -
cies in that this animal is relatively resistant to the
development of DDD. Notably, NCD canines preserve
their notochordal cell populations throughout life [2,3].
Thus, there is an emerging body of evidence indicating
that notochordal cells confer anabolic capacity upon NP
cells and that their absence is associated with suscept-
ibility to degenerative changes [2,4,5].
Apoptosis plays a central role in DDD development
Regulation of cellular turnover is vital to tissue homeos-
tasis. Apoptosis is a highly regulated form of pro-
grammed cell death that classically involves two main
pathways, the intrinsic (mitochondrial-dependent) and
extrinsic (death receptor or Fas-dependent) pathways. It
has been established that some cells, classified as Type I
cells, function independently of the mitochondria and
signal via Fas-induced apoptotic cell death involving the
caspase-8 pathway. Other cells have a critical reliance
upon the mitochondria whereby apoptosis is mediated
via caspase-9 and are known as Type II cells [6,7]. The
initial explorations of these pathways involved the use of
knock-out mice leading to the conclusions that some
tissues are primed to respond to apoptotic stimuli in a
Type I versus Type II manner [7,8].
The classic extrinsic (CD95/Fas receptor) apoptotic
pathway is activated by soluble Fas ligand (Fas-L) bind-
ing to the CD95 or Fas receptor that in turn activates
caspase-8 followed by sequential activation of execu-
tioner caspases-7 and -3 resulting in cell death (type I
cells) [9,10]. In type II cells (such as disc cells), there is
af o r mo f‘cross-talk’ between the extrinsic and intrinsic
systems (involving mitochondria) whereby CD95/Fas
receptor activation and subsequent caspase-8 activity
may not reach the threshold necessary to activate the
common executioner caspases-3/7. Bid, the BH3
interacting domain death agonist, serves as a vital inter-
mediary in the ‘cross-talk’ that can occur between the
intrinsic and extrinsic pathways [8]. Bid activation
results in degradation of the mitochondrial membrane
by blocking the anti-apoptotic action of Bcl-2, an outer
mitochondrial membrane protein [8,9]. This loss of Bcl-
2-mediated mitochondrial homeostasis leads directly to
mitochondrial swelling and rupture of the organelle and
r e l e a s eo fc y t o c h r o m eci n t ot h ec y t o s o l[ 8 - 1 0 ] .W i t h i n
the cytosol cytochrome c is directly involved with the
formation of the apoptosome and the activation of cas-
pase-9 that in turn activates downstream effector cas-
pase-3, -7 and -6 resulting in cell death [8]. In this
study, we assessed the apoptotic pathway(s) involved in
the IL-1b and FasL induced apoptosis of bovine NP
cells under hypoxic conditions. The NP cellular and
extracellular matrix (ECM) is a tightly regulated envir-
onment where homeostasis is maintained by the matrix
metalloproteinases (MMPs), the ADAMTS family of
enzymes (A disintegrin and metalloproteinase with
thrombospondin motifs), tissue inhibitors of metallopro-
teinases (TIMPS), and regulation of inorganic pyropho-
sphate (PPi) transport by ANK [11,12]. ANK
(progressive ankylosis/human homologue of progressive
ankylosis) is a transmembrane protein encoded by the
ANK gene that controls pyrophosphate levels in cells
and tissues of joints. The MMP and ADAMTS enzymes
function in a similar fashion to those in skin and carti-
lage, and in an integrated fashion, balance anabolic and
catabolic processes within the framework of ongoing tis-
sue remodeling [11,13]. Dysregulation of the activity of
the MMPs, ADAMTS and TIMP enzymes results in
increased catabolic activity and progression of DDD lar-
gely due to the influence of inflammatory cytokines, in
particular IL-1b and the cell surface ‘death receptor’
Fas/CD95 [14,15]. The inflammatory cytokine IL-1b is
widely regarded as a key factor in the progressive degen-
eration of the IVD NP and FasL has been shown to sen-
sitize disc cells to Il-1b mediated apoptosis-resulting in
a synergistic action upon disc cells that increases with
further degeneration [15]. It has recently been demon-
strated that with increasing disc degeneration the NP
displays elevated ANK protein expression and these
changes may be associated with hydroxyapatite deposi-
tion contributing to progression of degenerative disease
[12]. ANK is also known to preserve the differentiated
chondrocyte phenotype (a critical element in the devel-
opment of both DDD and osteoarthritis). In the pre-
sence of IL-1ß, chondrocytes express less hypertrophic
chondrocyte-specific markers and are thought to lose
their differentiated chondrocyte phenotype [16].
The progressive loss of viable cells and ECM integrity
within the IVD NP is a pivotal process that depends
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cell number, nutrition of the disc (endplate integrity and
diffusion characteristics), disc cell phenotype, and age
[17-19]. With respect to IVD cellular content, the per-
sistence of notochordal cells within the disc NP of cer-
tain animals such as the NCD canine is thought to
contribute uniquely to resistance to DDD. Here for the
f i r s tt i m ew ed e m o n s t r a t et h at soluble factors secreted
by notochordal cells (notochordal cell conditioned med-
ium or ‘NCCM’) are capable of protecting NP cells from
matrix protein degradation and pro-inflammatory cyto-
kine secretion induced by IL-1ß and FasL. Furthermore,
IL-1ß and FasL-mediated cell death is inhibited by
NCCM via the inhibition of activated caspases -9 and
-3. The ability to harness the restorative properties of
the notochordal cell may lead to novel, molecular thera-
pies in the treatment of DDD.
Materials and methods
Bovine NP cells
We obtained NP cells from the tails of 3-year old steers
(bovine caudal discs) to be used as the ‘target’ cells in
our experiments. Typically we harvested the NP from
five to six bovine tails and enzymatically digested the
NP overnight in order to obtain the cells. We removed
the nucleus pulposus from the caudal discs of five to six
bovine tails and after overnight digestion expanded the
cells through two passages and then after suspension in
10% DMSO with 90% FBS (4 × 10
6 cells/mL) froze the
cells at -80°C. We also developed bovine NP cell condi-
tioned medium (BCCM) in exactly the same fashion as
we obtained bovine NP ‘target’ cells but in the case of
BCCM cultured the bovine NP cells within alginate
beads.
Non-chondrodystrophic canine notochordal cells
We obtained the NP from the lower thoracic and entire
lumbar IVDs from 11 non-chondrodystrophic canines (6
in the first series of serum-free experiments and 5 in
the second 2% NCCM experiments) and after overnight
digestion seeded the cells within alginate beads for sub-
sequent culture.
Conditioned medium
We generated conditioned medium from both non-
chondrodystrophic canine notochordal cells (NCCM)
and bovine NP cells (BCCM). We then tested the ability
of bovine NP conditioned medium or canine notochor-
dal cell conditioned medium to protect bovine NP cells
from cell death in the presence of IL-1b+Fas ligand
(FasL). We also determined the ability of NCCM to pro-
tect the expression of salient extracellular matrix genes
and other molecules under these same in vitro condi-
tions using qRT-PCR methods. We used flow cytometry
and activated caspase assays to determine protection
from cell death and to discern the apoptotic pathways
involved.
Tissue harvest
Non-chondrodystrophic canine discs
A total of 11 dogs was used in the experiments; 6 ani-
mals in the first series of serum-free experiments and 5
in the second 2% NCCM experiments. All animals were
obtained in collaboration with a licensed animal facility
and all practices were in accordance with the animal
care policies and ethics approval board of Toronto Wes-
tern Hospital. All animals were 8 to 12 months of age
and had failed at adoption or were to be euthanized fol-
lowing biopharmaceutical intervention. Deep sedation
was achieved using a combination of Acepromazine
(Atravet-Aerst pharmaceuticals St. Laurent, Quebec,
Canada 10 mg/mL) mixed with Xylazine 100 mg/mL
(Xylomax-Bimeda-NHC Animal Health, Broomhill
Road, Tallaght, Dublin 24, Ireland) at a combined dose
of 1 mL/15 Kg body weight. Once deep sedation had
occurred, euthanasia was accomplished using intrave-
nous sodium pentobarbital (CDMV) (St. Hyacinthe,
Quebec, Canada at a dose of 30 mL/kg body weight.
Tissue culture conditions
Notochordal cell recovery
For each NCCM-related experiment, within one hour of
euthanasia, the lumbar spine was removed from six
dogs in one experiment and five dogs in another. After
soft tissue dissection the spines were treated with Cli-
dox™ and Betadine™, the NPs were removed asepti-
cally from six to eight IVDs of each animal and
transferred to Advanced Dulbecco’s Modified Eagle
Medium/F-12 (ADMEM/F-12) supplemented with 100
units penicillin/streptomycin (PS) (basal medium) (Life
Technologies, Carlsbad, Cal, USA). After removal of any
residual annulus fibrosus, the NP tissues were enzymati-
cally digested sequentially over night according to estab-
lished methods previously reported [4,5,20]. The
following day, the cells were filtered with a 70 μmc e l l
strainer (Falcon). This cell preparation was found to be
close to 100% notochordal in content, recognized by the
classic physaliferous, large vacuolated appearance of the
cells.
Serum-free notochordal cell conditioned medium
(NCCM) In order to determine the effect of notochordal
cell-secreted factors without any exogenous stimulatory
factors, we developed serum-free NCCM. Briefly, canine
NP cells were mixed with 1.2% sodium alginate at a
density of 1.5 × 10
6 cells/mL. Using a 21G needle and 5
mL syringe, the cell/alginate mixture was drop-wise
added to 4 mL of 102 mM CaCl2 at a density of 80
beads/well within 6-well plates (6 × 10
6 cells in total).
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within the CaCl2 mixture and then each well containing
the beads was washed 3 times with 150 mM phosphate
buffered saline (PBS). Finally, the wells containing the
alginate-notochordal cell beads were placed under
hypoxic tissue culture (3.5% O2, 37°C and 5% CO2) with
ADMEM/F12 supplemented with 8% fetal bovine serum
(FBS) and 100 Units (U) penicillin/streptomycin (PS) for
two days (complete medium). After two days of culture
in complete medium, the alginate beads containing the
notochordal cells were thoroughly washed with PBS (15
minutes per wash for two hours). The medium was
replaced with 6 mL/well (3 wells total) of basal medium
(FBS-deficient ADMEM/F-12 containing 100 U PS) and
after three more days of hypoxic culture serum-free
NCCM was harvested and used for subsequent tissue
culture.
2% FBS supplemented NCCM (2% NCCM) In order to
ensure that our caspase assay results would not be
skewed by the notochordal cells depleting the available
nutrients over the culture period, we generated 2%
NCCM using basal medium supplemented with 2% FBS
(2% basal medium) in order to provide a modest
amount of nutrients to sustain the notochordal cells.
For these experiments we obtained notochordal cells
from five separate NCD canines, exactly as above and
developed alginate beads containing notochordal cells at
a density of 0.75 × 10
6 cells/mL in a volume of 3 mL/
well (five wells). There is variable recovery of notochor-
dal cells from NCD canines and from this series of ani-
mals there were fewer cells recovered than in the
serum-free experiments. Therefore we reduced the con-
centration of the cells within the beads as well as the
volume of medium used for these experiments in order
to attempt to approximate the concentration of NCCM
developed. The beads containing notochordal cells were
cultured for two days in complete medium and then
washed extensively using basal medium (4 washes × 15
minutes) and the medium replaced using 2% basal med-
ium and cultured within 2% basal medium for three
days before harvesting. We refer to these supernatants
as 2% NCCM.
Bovine NP cells
Bovine NP cells (obtained earlier from caudal discs of
five to six three-year old steers were released by enzy-
matic digestion, filtered, counted, plated and cultured
under hypoxic conditions in T-75 flasks (CoStar-Corn-
ing Life Technologies, Corning, New York USA) in
complete medium. The cells were allowed to expand to
70% confluence, harvested using Trypsin (Sigma-Aldrich
Canada Ltd., Oakville, Ontario, Canada), and re-sus-
pended in 90% FBS and 10% DMSO. Next the cells
were sequentially frozen first at -80°C for two days and
then transferred to liquid nitrogen. The day that the
canine notochordal cells were harvested, we thawed the
bovine NP cells in a 37°C water bath and after washing
with complete medium the cells were plated and
allowed to expand to 70% confluence at 37°C under
hypoxic conditions of 3.5% O2 and 5% CO2. Coincident
with the development of NCCM, the bovine NP cells
were trypsinized, extensively washed with basal medium
and re-seeded within 6-well plates at 0.5 × 10
6 cells/well
and placed under hypoxia and allowed to expand for 3
days to 80% confluence using complete medium.
Twenty-four hours prior to the NCCM-related experi-
ments the plated bovine NP cells were extensively
washed with basal medium and then cultured in basal
medium in preparation for the NCCM experiments. For
the 2% NCCM experiments, we initially thawed bovine
NP cells and expanded them using complete medium,
then washed them three times with 2% FBS supplemen-
ted basal medium in preparation for these experiments.
2% FBS supplemented bovine NP conditioned medium (2%
BCCM)
In order to be sure that any beneficial effects conferred
by NCCM were not simply a cell-induced artifact, we
compared the effects of 2% NCCM to conditioned med-
ium made from bovine NP cells also supplemented with
2% FBS. Therefore we obtained bovine NP cells from
the caudal discs of five to six three-year old steers,
seeded them within alginate beads, cultured them within
basal medium supplemented with 2% FBS to develop
‘2% BCCM’. We then used 2% BCCM in exactly the
same fashion as 2% NCCM to test its effect upon bovine
NP cells.
Induction of apoptosis
We induced apoptosis of monolayer cultured bovine NP
cells by the addition of 10 ng/mL recombinant bovine
IL-1b (Thermo Scientific RP-87269 Nepean, Ontario,
Canada) plus 10 ng/mL recombinant human Fas-ligand
(FasL) (Alexis Biochemical Alx-522-001 San Diego, CA
USA)). We then evaluated cell death using flow cytome-
try (after 48 hours) and activated caspase assays (after
24 hours). These time points were chosen after optimi-
zation experiments.
Protection from apoptosis and degradation
In order to determine if factors secreted by notochordal
cells could specifically inhibit apoptosis and degradation
of bovine NP cells, we cultured bovine NP cells with
NCCM, 2% NCCM, and 2% BCCM, all in the presence
of IL-1ß+FasL. For controls, we cultured bovine NP
cells with basal medium for the flow cytometry experi-
ments or with basal medium supplemented with 2%
FBS; in all cases identical doses of IL-1b,o rI L - 1 b +
FasL were used. All experiments were performed at 37°
C under hypoxic conditions of 3.5% O2 and 5% CO2.
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Flow cytometry
Three 6-well plates containing bovine NP cells that had
achieved approximately 80% confluence were divided
such that each well of a 6-well plate received 4 mL/well
of basal medium only (0% FBS medium), 1 plate
received basal medium plus 10 ng/mL IL-1b +F a s L /
well, and one plate received 4 mL of serum-free NCCM
+I L - 1 b+FasL/well. All samples were cultured under
hypoxic conditions for 48 hours following which we
determined differential cell death using flow cytometry.
Caspase-3 validation
In parallel to the flow cytometry experiments, bovine
NP cells were cultured in two additional 6-well plates.
S i xw e l l so fo n ep l a t er e c e i v e dt h es a m ev o l u m eo f
serum-free basal medium (4 mL) and six wells in the
other plate received serum-free basal medium + IL-1b +
FasL. These plates were then processed to evaluate the
induction of apoptosis using the Apo-Alert activated
caspase-3 assay.
Caspase -8, -9 and -3/-7 assays
Separate experiments were performed using basal med-
ium supplemented with 2% FBS, 2% NCCM and 2%
BCCM and the expression of activated caspases was
determined using the Caspase-Glo assay (Promega,
Madison Wis, USA). We chose the Caspase-Glo assay
for these experiments because this assay requires far
fewer cells/assay. The 2% NCCM was generated from
notochordal cells obtained from six to eight discs from
five canine spines and the ‘target’ bovine NP cells were
obtained from the discs of five to six three-year old
steers. In this way we repeated our cell-death assays
using cells obtained from entirely separate pools of cells
from groups of animals in this case using activated cas-
pase assays.
Gene Expression
We obtained total RNA from the same sets of cultures
from which we assessed cell death using flow cytometry
(serum-free basal medium only (0% FBS medium),
serum-free basal medium plus 10 ng/mL IL-1b+FasL/
well, and serum-free NCCM+IL-1b+FasL/well. Briefly,
after the 48-hour culture period total RNA was
extracted from each of three wells for each condition
using Trizol™ Life Technologies, Carlsbad, CA, USA)
according to the manufacturer’s recommendations. The
RNA was purified, quantified using Nanodrop™
(Nepean, Ontario, Canada) and after reverse transcrip-
tion, real-time RT-PCR evaluation for the genes of inter-
est was performed.
Evaluation of Cell Death
Flow Cytometry
We used flow cytometry (Becton Dickinson Dual Laser
FacsCalibre (Mississauga, Ontario, Canada)) to evaluate
the total extent of bovine NP cell death and apoptosis
by incubating the cells in appropriate buffers and label-
ing with Propidium Iodide (PI) and Annexin-V (AV),
(Sigma-Aldrich Canada Ltd., Oakville, Ontario, Canada)
respectively, according to the manufacturer’si n s t r u c -
tions. AV is a protein that preferentially binds to phos-
phatidyl serine (PS) which undergoes specific changes
during apoptosis and when conjugated to fluorescein
isothiocyanate (FITC) it is capable of detecting early
apoptosis via fluourescence imaging. PI is capable of
entering the cell only when the plasma membrane has
been dirsupted and is a non-specific marker of cell
death which is often used together with AV to discrimi-
nate apoptosis from necrotic cell death. AV (to detect
apoptotic cells) and PP (to detect dead/necrotic cells)
were added to each sample according to the manufac-
turer’s instructions and incubated at room temperature
in the dark for 10 minutes. The cell harvest was filtered
using 70 μm cell strainers (Falcon) just prior to flow
cytometry analysis for which we used ‘FacsCalibre’.D a t a
analysis was performed using CellQuest Pro.
Flow Cytometry Optimization
We adjusted the initial scatter plot to avoid small cells
or sub-celluar debris and then subsequent gating around
dead cells (AV+ and PI+ cells) determined from analysis
of cells treated with distilled H20. Our experimental
data were obtained using the gating protocols we devel-
oped from the positive (distilled H20) and negative
(untreated cells) controls. Necrotic cells were interpreted
as PI-positive and AV-negative and cells undergoing
apoptosis as AV+ and PI-. Cells that were both PI+ and
AV+ were considered to be mixed populations (apopto-
tic or necrotic). We used serum starvation and etopo-
side, known inducers of apoptosis as positive controls
and verified using flow cytometry (AV+ and PI- cells)
that serum starvation and 300 μM etoposide induces
discriminate populations of AV+ and PI- populations.
We pooled bovine NP cells obtained from the caudal
discs of six animals and used these cells as the ‘target
cells’. NCCM was generated from pooled notochordal
cells obtained from six to eight IVDs from each of six
non-chondrodystrophic canines as detailed above. All
treatments were performed in triplicate with cells incu-
bated for 48 hours under hypoxia. The cells from each
well were then collected individually by trypsinization
(both suspended/dead cells plus monolayer cells were all
collected for total cell recovery) and subjected to trypsin
inactivation by two washes with complete medium,
washed in ice cold PBS and re-suspended in 1 mL bind-
ing buffer (AnnexinV apoptosis detection kit, K101-100,
Cedarlane (Burlington, Ontario, Canada)). Untreated
cells re-suspended in DH20 for 15 minutes prior to add-
ing binding buffer were used as a positive control for
dead cells. We quantified our results by determining the
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PI+ (necrotic) cell populations. For each experimental
condition we calculated the percent of apoptotic cells as
a function of the total percent of dead cells and
expressed the results graphically (Figure 1). We deter-
mined the statistical significance for protection from
apoptosis by the use of the T-test for the cells treated
with IL-1b+FasL compared to the NCCM+ IL-1b+FasL
conditions.
In order to ensure that our flow cytometry results
were reliable in the detection of apoptotic events we
evaluated the expression of caspase-3 in cells treated
with complete medium only, as well as complete med-
ium plus IL-1ß + Fas. These cells were then processed
according to the manufacturer’s protocol and assayed by
flurometry (ApoAlert Caspase-3 Fluorescent assay kit,
ClonTech Labs inc., #630215 (Mountainview California,
USA). The caspase-3 assay detects an alteration in the
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Figure 1 Flow Cytometry Analysis of NCCM-Induced Protection from Apoptosis in NP Cells. (A) Representative sample of flow cytometry
analysis of bovine NP cell death (Propridium Iodide (PI) (Y axis) and Annexin V (X axis) staining. All experiments were performed in triplicate.
NCCM was generated from notochordal cells from six canine specimens. (a) 0% (basal medium) control, (b) IL-1b + FasL, (c) IL-1b + FasL +
NCCM (b) The use of IL-1b + FasL causes an increase in the PI+ and Annexin V+ cells (upper right quadrant = dead cells) as compared to either
(a) or (c). PI+ and Annexin V- = necrosis; PI + and Annexin V+ = apoptotic cell death. Treatment with NCCM (c) results in far fewer cells that are
PI+ and Annexin V+ with an appearance that is almost equivalent to baseline (a). The black oval in (b) represents the cell population within the
IL-1b + FasL treated cells that are ‘rescued’ by NCCM since these increasingly Annexin V+ and progressively PI+ cells are not apparent in the
NCCM-treated groups. Triplicate experiments are presented in graphically in Figure 1 (b). (B) Summary of flow cytometry NP cell death assays
(triplicate experiments as depicted in Figure 1 (a) above. The dark bars depict the percentage of all dead cells (Annexin V+ plus PI+) and the
white bars depict the percentage of the total dead cells for each condition that died via apoptosis (Annexin V+ but PI-). There is little death in
the untreated (0% (basal) media) cells but there is a marked increase in cell death when treated with IL-1b + FasL. This increase in both total cell
death (from 2.5% to 8.8%) and apoptotic cell death (from 31.69% to 46.2%) is brought almost to baseline by the use of NCCM (apoptotic cell
death is brought back to a level that is identical to the untreated cells). The differences between IL-1b + FasL and IL-1b + FasL + NCCM in terms
of both total and apoptotic cell death are statistically significant at P = .016 and P = .0002 respectively (see asterisk indicating significance).
Treatment with IL-1b + FasL + NCCM results in the most cell death as a function of apoptotic, not necrotic cell death. Abbreviations: IL-1b
(Interleukin-1beta) FasL (Fas Ligand), NCCM (notochordal cell conditioned medium),
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methyl coumarin (AFC). The emission spectra shift
from 400 nm to 505 nm after the AFC-labeled caspase-
3-specific substrate is proteolytically cleaved by the
enzyme and releases free AFC. Thus fluorescence inten-
sity at 505 nm is directly proportional to activated cas-
pase-3 and is representative of apoptotic events. These
optimization experiments validated that our flow cyto-
metry assay can reliably detect apoptosis in NP cells
(Additional file 1).
Activated caspase -8, -9 and -3/7 assays
Flow cytometry can discriminate between non-apoptotic
and apoptotic cell death but does not define the
mechanisms of such cell death or protection from apop-
tosis in the case of NCCM treated cells. Therefore, we
examined the expression of activated caspases-8, -9 and
-3/7 using the Caspase-Glo assay (Promega). This assay
was selected because it required far fewer cells com-
pared to the ApoAlert assay used to validate our flow
cytometry data allowing the relatively small amounts of
NCCM generated to be used in quadruplicate. Briefly, in
this assay the caspase enzyme specific luminogenic-sub-
strate is cleaved by active caspases in the cell lysate
releasing a substrate for luciferase. We plated bovine NP
cells in 96 well plates at a density of 1 × 10
4 cells/well.
The bovine NP cells were then incubated overnight with
complete media under our hypoxic conditions. The fol-
lowing day the cells were washed and incubated with
basal medium for three hours prior to treatment. There
were three treatment groups: (1) bovine NP cells cul-
tured with 2% ADMEM/F12 and treated with IL-
1ß+FasL, (2) bovine NP cells cultured with 2% BCCM
in the presence of IL-1ß+FasL and (3) NP cells cultured
with 2% NCCM in the presence of IL-1ß+FasL. All
treatment groups have a final volume of 100 ul/well.
After the 24-hour treatment period, 100 ul caspase
reagent was added to each well according to the experi-
mental design. For caspase -8 and -9, the proteosome
inhibitor MH-132, 60 uM, was added to the caspase
reagent just prior to use. The plates were then incubated
at room temperature for 75 minutes and luminescence
detected with Perkin Elmer Victor3 Multilabel coulter
(Model 1420-050). For background controls, we mea-
sured control luminescence from wells containing treat-
ment media and the caspase reagent but no cells (Av
lum - Av background lum = Relative Luminescence). All
assays were performed in triplicate and the results
examined statistically using the T-test.
Gene Expression Analysis
We wished to determine if serum-free NCCM could
protect the expression of important extracellular matrix
(ECM) genes as well as the pain- and inflammatory-
related cytokine IL-6. We used real-time RT-PCR (qRT-
PCR) to examine the expression of ECM genes, aggre-
can, collagen type 2 and the cell-surface glycoprotein
hyaluronic acid assembly site; CD44 and link protein.
We also examined the expression of genes encoding
matrix protecting factors such as TIMP-1, the principal
matrix degrading enzymes MMP-3 and ADAMTS-4 and
the expression of IL-6 by NP cells. Finally, we also
examined the capacity of NCCM to affect the expres-
sion of the Ank gene by bovine NP cells treated with
IL-1ß+FasL. We evaluated the expression of these genes
in bovine NP cells cultured with basal medium, basal
medium supplemented with IL-1ß, basal medium sup-
plemented with IL-1ß+FasL and finally serum-free
NCCM-treated NP cells also in the presence of IL-
1ß+FasL.
qRT-PCR Optimization
Each primer pair was optimized for both optimal primer
concentration and amount of cDNA in order to deter-
mine that amplification was within 15 to 25 amplifica-
tion cycles. By this approach, we avoided non-linear/
endpoint amplification data. We evaluated the expres-
s i o np r o f i l ef o re a c hp r i m e rp a i ru s e dt oe n s u r et h a t
there were no aberrant peaks present during the amplifi-
cation phase of the PCR reaction. In addition to examin-
ing the expression of the various genes of interest when
cultured with serum-free NCCM we also repeated our
experiments using total RNA obtained from the 2%
NCCM experiments.
Primers were obtained using previously published
studies and established databases [21]. All other pri-
mers were designed using Primer Express 3.0 accord-
ing to standard guidelines, based on bovine coding
sequences of each gene of interest (Table 1). Each pri-
mer set was optimized to determine the optimal pri-
mer concentration, annealing temperature and cDNA
concentration. Total RNA was extracted from cells
using Trizol reagent (Sigma) according to the manu-
facturer’s recommendations. For cDNA synthesis,
reverse transcription was performed on 1 ug of total
RNA sample using SuperScript II based reverse tran-
scription system (Life Technologies, Carlsbad, Califor-
nia, USA) Invitrogen. The RT-PCR analysis was
performed using the iCycler iQ5 RT-PCR detection
system (BioRad Laboratories Mississauga, Ontario,
Canada) and iQ SYBR green Supermix (BioRad
Laboratories). Primer sets with equitable efficiencies
were determined based on cDNA standard curves and
were used for quantitative RT-PCR analysis using the
delta-delta-Ct method [22]. We normalized the expres-
sion of the target genes using the constitutively
expressed gene hypoxanthine guanine phosphoribosyl-
tranferase (HPRT). The threshold for determining sig-
nificant changes in the normalized expression of genes
of interest was established at a 1.5-fold difference in
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tistically evaluated using the T-test with significance
denoted by asterisks at P < .05 (unless otherwise
noted).
Fold changes in gene expression were determined by
dividing the mean ΔΔCT value calculated for each gene
of interest for the IL-1b+FasL culture experiments by
the mean ΔΔCT obtained for IL-1b+FasL+NCCM for
each gene of interest (DD-CT fold change = (IL1B
+FASL)/(IL1B+FASL+NCCM) (Table 2).
Results
IL-1b and FasL mediated apoptosis in hypoxic bovine NP
cell culture can be rescued by NCCM
We induced apoptosis of monolayer cultured bovine NP
cells by the addition of 10 ng/mL recombinant bovine
IL-1b plus 10 ng/mL recombinant human Fas-ligand
(FasL) and evaluated cell death by flow cytometry (after
48 hours) and by the caspase assays (after 24 hours).
T h e s et i m ep o i n t sw e r ec h o s e na f t e ro p t i m i z a t i o n
experiments. AV and PI labelled cells were quantified
using flow cytometry allowing discrimination between
viable/intact cells (AV-PI-), early apoptotic (AV+PI-)
and late apoptotic or necrotic cells (AV+PI+). Cells
were harvested from each of three conditions and after
analysis using flow cytometry the percentage of dead
cells in each condition was determined. Next from the
dead cell populations the percentage of dead cells that
were considered apoptotic was expressed as a function
of the total percentage of dead cells (Figure 1). Treat-
ment with NCCM resulted in a significant reduction in
PI/AV positive cells that was similar to baseline levels
with the rate of apoptotic cells indistinguishable from
baseline (Figure 1, Panel c). We used an activated cas-
pase-3 fluorometric assay to evaluate parallel bovine NP
cells treated with IL-1b+FasL and found that this treat-
ment induced apoptosis as demonstrated by the detec-
tion of activated caspase-3 (Additional File 1 Figure S1).
Flow cytometry can discriminate between non-apopto-
tic and apoptotic cell death but does not define the
mechanisms of such cell death or protection from apop-
tosis in the case of NCCM treated cells. In order to
determine the mechanisms underlying NCCM-mediated
Table 1 Real-time RT-PCR Primers, annealing temperatures and Accession Numbers of genes evaluated
Gene Primer Sequence Annealing Temp °C Accession Number
Aggrecan F CCTGAACGACAAGACCATCGA 58 U76615
Aggrecan R TGGCAAAGAAGTTGTCAGGCT 58
Collagen 2 F AAGAAGGCTCTGCTCATCCAGG 58 X02420
Collagen 2 R TAGTCTTGCCCCACTTACCGGT 58
MMP3 F CACTCAACCGAACGTGAAGCT 58 AF135232
MMP3 R CGTACAGGAACTGAATGCCGT 58
TIMP1 F TCCCTGGAACAGCATGAGTTC 58 AF144763
TIMP1 R TGTCGCTCTGCAGTTTGCA 58
ADAMTS4 F CCTGGCAACGAGGACTCAAC 58 NM_181667.1
ADAMTS4 R GGGTAAACAGAATGGCTGTGTCA 58
CD44 F CGGGTTCATAGAAGGGCATGT 58 X62881.1
CD44 R TTGTTCGCAGCACAGATGGA 58
Link protein F AAGCTGACCTACGACGAAGCG 58 NM_174288.1
Link protein R CGCAACGGTCATATCCCAGA 58
IL-6 F CTGGGTTCAATCAGGCGAT 58 NM_173923.2
IL-6 R CAGCAGGTCAGTGTTTGTGG
ANKH F
ANKH R
TCGGTGTGGACTTTGCCTTT
ACTGGAACCGGGAAGAAGGA
58 NP_001103263
Table 2 Normalized fold changes (HPRT) in gene
expression by NP cells cultured in NCCM and treated
with IL-1b+FasL
Gene Normalized Fold Change in Gene Expression
Collagen Type 2 1.57 fold increase
Aggrecan 65.5 fold increase
Link Protein 54.5 fold increase
CD44 Receptor 1.76 fold increase
MMP3 1.53 fold decrease
ADAMTS4 3.4 fold increase
TIMP1 4.8 fold increase
IL-6 1.9 fold decrease
Ank 1.5 fold decrease
’Fold change’ was calculated by dividing the mean ΔΔCT value for each gene
of interest treated with IL-1b + FasL/mean ΔΔCT for cells treated with IL-1b +
FasL + NCCM. The gene expression data which is presented graphically in
Figures 4 to 6 is normalized to basal medium conditions (bovine NP cells
treated with basal medium without the addition of IL-1b or IL-1b + FasL.
Abbreviations: CD44 (cluster of differentiation 44), MMP3 (matrix
metalloproteinase-3), ADAMS4 (A disintegrin and metalloproteinase with
thrombospondin motifs 4), TIMP-1 (tissue inhibitor of matrix
metalloproteinase-1), IL-6 (interleukin-6), Ank (Ank gene).
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activity of bovine NP cells treated with 2% NCCM and
2% BCCM versus basal medium supplemented with 2%
FBS in the presence of IL1-b+FasL. There are no differ-
ences in the expression of activated caspase-8 in any of
the treatment groups (Figure 2(a)). Both 2% NCCM and
2% BCCM significantly suppressed the expression of
activated caspase-9 activity (both P < 0.01; Figure 2(b)).
However, only 2% NCCM (but not 2% BCCM) signifi-
cantly suppressed the expression of caspase-3/7 in the
IL1b and FasL treated bovine NP cells (P <0 . 0 1 ;F i g u r e
2(c)). As activated caspase-3/7 are downstream effectors
leading to apoptosis, only 2% NCCM has the factors to
partially rescue IL1-b and FasL mediated apoptosis in
bovine NP hypoxic cultures.
Impact of NCCM on genes encoding structural proteins
and modulators of the extracellular matrix
Structural protein gene regulation
The use of NCCM in cultures co-treated with IL-1b had a
significant effect upon genes that encode structural pro-
teins as well as the inhibitors and activators of extracellu-
lar matrix remodeling (Figures 3 and 4). We have
presented our results relative to basal conditions (cells
treated with basal medium without IL-1b or FasL). Consis-
tent with past reports, aggrecan gene expression was
decreased with the use of ILl-1b and IL-1b+FasL
[14,15,23,24]. However, NCCM up-regulated aggrecan
gene expression and demonstrated a markedly increased
65.5-fold difference compared to basal medium conditions
(Table 2). Interestingly, NCCM also increased the expres-
sion of the gene encoding link protein to a 54.5-fold
increase over baseline. NCCM up-regulated CD44 expres-
sion by 1.76-fold and inhibited the down-regulation of col-
lagen 2 induced by IL-1b+FasL by 1.76-fold (Table 2).
Extracellular matrix remodeling and anti-inflammatory
cytokines
The expression of extracellular matrix remodeling genes
was protected by the use of NCCM. MMP3 gene
expression is up-regulated by IL-1b and IL-1b+FasL but
the gene expression of this catabolic enzyme is reduced
by 1.5-fold by NCCM. The activity of the MMP inhibi-
tor TIMP-1 is up-regulated by NCCM 4.8-fold and a
3.4-fold increase was observed in the expression of
ADAMTS4 (Table 2) [25-27].
The use of IL-1b+FasL led to a strong increase in the
expression of the IL-6 gene but the addition of NCCM
to the cultures markedly down-regulated IL-6 gene
expression by almost 50% (1.9-fold reduction).
Ank gene expression and NP cell phenotype
The expression of ANKH (human homolog of Ank)i s
increased with increased amounts of human IVD degen-
eration suggesting that the ANK pathway may play a key
role in the homeostatic regulation of the IVD [11,28].
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Figure 2 Activated caspase assays for NP cell apoptosis. (a) Activated caspase-8 activity for all experimental conditions; there is marginally
increased activity in NCCM + IF and further elevated activity for BCCM but no suppression of activated caspase-8 activity for any of the
treatment groups. (b) Activated caspase-9 activity is upregulated in the 2% +IF group and markedly down-regulated by NCCM (P < .01) and also
(although to a lesser extent) by BCCM (P < .01). (c) Levels of activated caspase-3 for 2%, 2% + IL-1b + FasL, NCCM + IL-1b + FasL and BCCM +
IL-1b + FasL treated cells. Here the use of NCCM in the presence of IL-1b + FasL reduces activated caspase-3 activity to almost baseline -
precisely as demonstrated using flow cytometry and AnnexinV and PI labeling. Interestingly, there is no protection from apoptosis using
conditioned medium obtained from bovine NP cells (BCCM) indicating that anti-apoptotic signaling is uniquely conferred by NCCM (P < .01).
The suppression of both activated caspase-3 and -9 by treatment with NCCM indicates an anti-apoptotic effect of NCCM upon NP cells in the
presence of IL-1b + FasL that is not accounted for by the other treatment groups. RLU (depicted on the ‘Y’ axis) is the fluorometric activity that
occurs in the presence of caspase activation that releases a substrate for luciferase that in turn is determined using fluorometric methods. In
each case 2% NCCM was generated from pooled notochordal cells obtained from the IVDs of five non-chondrodystrophic canines (eight to nine
discs/animal). Bovine NP cells were obtained from the caudal discs of five to six three-year old steers. The 2% BCCM was generated from a
separate pool of bovine caudal discs similarly obtained, seeded within alginate beads and conditioned medium developed over three days.
Abbreviations: IL-1b (Interleukin-1beta) FasL (Fas ligand), NCCM (notochordal cell conditioned medium), BCCM (Bovine Cell Conditioned
Medium), NP cells (nucleus pulposus cells), RLU (Relative Luminescence Units).
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in NP cell expression of the Ank gene in our system. In
keeping with prior studies on articular cartilage, down-reg-
ulation of the Ank gene expression was observed after the
addition of IL-1b and IL-1b+FasL. This process was inhib-
ited by NCCM by 1.5-fold (Figure 5) (Table 2).
Discussion
The hallmark of progressive DDD is the inability of NP
cells to maintain normal homeostatic tissue remodeling
under the influence of increased cytokine and death
receptor expression [11,12,18,26]. A number of studies
have strongly implicated IL-1b+FasL as key molecules in
the progression of DDD [11]. The purpose of this study
was to determine the ability of NCCM to (1) counteract
the deleterious gene expression changes induced by IL-
1b+FasL in vitro; and (2) inhibit apoptosis of NP cells
and determine the signaling pathways involved. Here we
demonstrate for the first time that soluble factors
secreted by notochordal cells strongly protect NP cells
from IL-1b+FasL induced degeneration and apoptosis.
Of significance NP cell apoptosis is inhibited by NCCM
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Figure 3 Quantitative Real-time PCR (qRT-PCR) relative gene expression for collagen type 2, Aggrecan, Link Protein and the CD44 receptor
expressed by bovine NP cells. The expression of each gene represented is expressed relative to basal (untreated) conditions and is normalized to
the constitutively expressed gene HPRT. Reading each graph from left to right is the relative fold gene expression of NP cells treated with IL-1b (grey
bar), IL-1b + FasL (black bar), cells treated with IL-b + FasL + NCCM (white bar). NCCM was developed from the NPs from six dogs, the NP cells from
the NPs of five to six bovine caudal discs cells pooled together. All qRT-PCR experiments were repeated in quadruplicate and are presented with
standard error calculations performed for all conditions (statistical significance is P < .05). Abbreviations: qRT-PCR (quantitative Real-Time Polymerase
Chain Reaction), CD44 (cell surface glycoprotein cluster of differentiation 44), HPRT (Hypoxanthine-guanine phosphoribosyltransferase), NP cells
(nucleus pulposus cells), IL-1b (Interleukin 1 beta), FasL (Fas Ligand), NCCM (notochordal cell conditioned medium).
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Page 10 of 15and is mediated in a caspase-dependent manner via sup-
pression of activated Caspase -9 and -3/-7.
Gene expression which leads to the protective effect of
NCCM
Progressive DDD is associated with increased expression
of IL-1b [14,15,23,29,30] and FasL. We showed that IL-
1b- and FasL-induced bovine NP cells under hypoxic
conditions provide an appropriate system for the dissec-
tion of mechanisms underlying IVD degeneration. Our
results indicated that changes induced by IL-1b are
further stimulated by the addition of FasL. Thus, we
used this in vitro system to identify the deleterious
genes which can be counteracted by NCCM. Our RT-
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Figure 4 Relative gene expression for MMP-3, ADAMTS-4, TIMP-1 (matrix remodeling genes) expressed by bovine NP cells (real-time
PCR (qRT-PCR). Reading from left to right on each graph the grey bar reflects NP cells treated with IL-1b, the black bar is treatment with IL-1b
+ FasL, and the white bar NP cells treated with IL-1b + FasL + NCCM. As in Figure 3 each gene represented is expressed relative to basal
(untreated) conditions and normalized to the constitutively expressed gene HPRT. NCCM was developed from notochordal cells obtained from
the NPs of six non-chondrodystrophic canines and pooled together. Bovine NP (target cells) were collected from bovine caudal discs of five
animals and pooled together. All qRT-PCR experiments were repeated in quadruplicate and are presented above with standard error calculations
performed for all conditions. The statistical significance for NCCM-treated cells relative to IL-1b + FasL is indicated by the asterisk and indicator
bars and is P < .05. Abbreviations: MMP-3 (matrix metalloproteinase-3), ADAMTS-4 (A disintegrin and metalloproteinase with thrombospondin
motifs 4), TIMP-1 (tissue inhibitor of matrix metalloproteinase 1), IL-1b (Interleukin 1 beta), FasL (Fas ligand), NCCM (notochordal cell conditioned
medium), qRT-PCR (quantitative real-time polymerase chain reaction).
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Figure 5 Bovine NP cell expression of IL-6 and Ank genes (qRT-PCR). (a) Expression of IL-6 gene by NP cells treated with IL-1b,I L - 1 b +
FasL, and IL-1b + FasL + NCCM. IL-1b, IL-1b + FasL induce a dramatic increase in the expression of the gene encoding IL-6; however, the use of
NCCM results in a dramatic reduction of NP cell expression of IL-6. (b) NP Ank gene expression is significantly down-regulated by the use of IL-
1b, IL-1b + FasL; however, this down-regulation is strongly attenuated by NCCM. NCCM was developed from the IVDs of six non-
chondrodystrophic canines and pooled together. Bovine NP (target cells) were collected from bovine caudal discs of five animals and pooled
together. All qRT-PCR experiments were repeated in quadruplicate and are presented above with standard error calculations performed for all
conditions. The statistical significance for NCCM treated cells relative to IL-1b + FasL is indicated by the asterisk and indicator bars and is P < .05.
Abbreviations: IL-6 (Interleukin-6), qRT-PCR (quantitative real-time polymerase chain reaction), NCCM (notochordal cell conditioned medium), IL-
1b (Interleukin 1 beta), FasL (Fas ligand), NCCM (notochordal cell conditioned medium), qRT-PCR (quantitative real-time polymerase chain
reaction).
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is mainly due to (1) the inhibition of the transcript
expression of a proinflammatory cytokine, IL-6, and a
major collagenase, MMP-3 (likely via upregulation of
TIMP-1, a natural inhibitor of MMP-3); and (2) the
homeostatic regulation of matrix synthesis involving the
maintenance of aggrecan (likely via increased expression
of ADAMTS4), link protein and CD44 expression.
1. IL-6
It has been shown that IL-6 expression is increased in
DDD and is correlated with painful degenerative discs
[31,32]. As reported by others, treatment of NP cells
with IL-1b alone or together with FasL led to upregula-
tion of IL6 transcript expression [33]. The use of
NCCM downregulated its expression by more than 50%,
suggesting that factors in NCCM, in part, inhibit the
inflammatory aspect of disc degeneration.
2. MMP3 (stromelysin)
MMP-3 is a major collagenase involved in the irreversi-
ble degradation of collagen [24]. TIMPs bind to MMPs
and protect proteoglycan degradation [31]. Our results
showing up-regulation of TIMP-1 and down-regulation
of MMP-3 transcripts, respectively, suggested that
NCCM conferred an anti-degradative effective on the
IL-1b- and FasL-treated MP cells.
3. ECM homeostasis
As part of the degenerative process, degraded link pro-
tein and proteoglycans accumulated in NPs much faster
than in articular cartilage [34,35]. Recently, aggrecan
degradation and turnover has been shown to be a rever-
s i b l ee v e n t ,i n d i c a t i n gt h e r em i g h tb eaw i n d o wo f
opportunity whereby proteoglycan degradation could be
prevented before the irreversible MMP-mediated degra-
dation occurs [21,22]. It is possible to restore disc height
and increase T2 MRI signals after trophic factors deliv-
ery to the disc following initial chemonucleolysis and/or
needle puncture [35,36].
We and others showed that IL-1b induced NP cells to
up-regulate the transcript expression of molecules
involved in ECM modeling (ADAMTS-4 and CD44)
[14,23]. Our results showing that NCCM upregulated
ADAMTS-4 and CD44 expression may support the
notion that some NCCM factors stimulate the remodel-
ing process to preserve collagen type 2, aggrecan and
link protein. The ADAMTS family of aggrecanases
(notably ADAMTS-4 in the disc NP) functions in a
reversible fashion to degrade the aggrecan core protein
[24]. Aggrecan plays an important role in the hydration
of NP, mainly by binding to hyaluronic acid and being
stabilized by link protein [32,33]. Our observation that
NCCM maintained the expression of aggrecan, CD44
and link protein reiterated that part of the protective
effects of NCCM is mediated via maintenance of ECM
homeostasis.
4. Ank/ANKH
T h e r ei se m e r g i n ge v i d e n c et h a tA n k / A N K Hp l a y sa
role in IVD degeneration. The best documented ANK
function involves regulation of inorganic pyrophosphate
(PPi) transport across the cell membrane [16]. It is also
involved in differentiation of cell lineages such as osteo-
blast and osteoclasts [36]. In rat NP cells, hypoxia regu-
lates Ank gene expression [12] and ANKH expression is
increased in degenerated human IVDs [12], leading to
the hypothesis that loss of homeostatic regulation of PPi
is involved in degeneration and calcification in the IVD.
In another study, IL-1b-treated chondrocytes in vitro
resulted in a loss of differentiated chondrocyte pheno-
type (diminished Sox2, aggrecan and collagen II tran-
scripts) and diminished Ank expression [16]. We noted
a similar effect upon bovine NP cells treated with IL-1b
with or without FasL in which reduced Ank gene
expression occurred and this down-regulated Ank
expression was attenuated by NCCM. However, our
experiments were short term only (24 to 48 hours) and
were performed on single cell in vitro cultures devoid of
the complexities and feedback from the extracellular
matrix and long-term degenerative changes that occur
in vivo. It remains to be investigated whether NCCM
contains sufficient PPi levels that contribute partly to its
protective effect. Nonetheless, our in vitro results show-
ing down regulation of Ank expression in treated NP
cells (when taken together with down regulated aggre-
can and collagen type 2 gene expression) appear to be
consistent with a loss of phenotype maintenance known
to occur in chondrocytes treated with IL-1b.T h en o t a -
bly partial rescue of Ank gene expression by NCCM is
suggestive of a homeostatic/protective effect conferred
upon NP cells by the components of notochordal cell-
secreted factors.
Mechanistic dissection of the protective effect of NCCM
on NP cell apoptosis induced by IL-1b and FasL
Figure 6 provides a synopsis of the signaling pathways
involving the CD95/Fas death receptor (extrinsic system)
and the intrinsic pathway mediated by the mitochondria.
Type II cells (such as disc cells) utilize both the extrinsic
and intrinsic pathways. We took advantage of the
upstream/downstream effector caspases in the FasL
mediated apoptotic pathways to evaluate the step(s) in
which the NCCM factors exert their protective effects.
Caspase-8 is upstream of the pathway close to the Fas/
CD95 receptor; and caspase-9 and -3 are downstream of
the mitochondrial effects while caspase-3 is the apopto-
sis executioner. The presence of NCCM in the IL-1b-
and FasL-treated NP cells inhibited activation of both
caspase-9 and -3 while BCCM inhibited only activation
of caspase-9. This significant result positioned the pro-
tective effects of NCCM factors to events downstream
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Figure 6 Schematic of mitochondrial pattern of apoptosis in type II Nucleus pulposus cells. 1. Caspase-9 activation via cross talk from Fas-
receptor and caspase-8 induced Bid-T-Bid induction of cytochrome c release by mitochondria and downstream apoptosis ultimately via
activation of caspase-3. 2. Potential areas where NCCM/BCCM (dotted boxes) may function upstream of activated caspase-9. 3. Potential
mechanisms of action of NCCM downstream of activated caspase-9 via may function to inhibit activated caspase-9 and its function within the
apoptosome, inhibit XIAP-like activity or by anti-Smac/Diablo activity resulting in inhibition of pro-apoptotic function of Smac/Diablo. 4. NCCM
may function or contain XIAP or XIAP-like inhibitors of apoptosis or it may function to inhibit activated caspase-9 and its function within the
apoptosome. Abbreviations: NCCM (notochordal cell conditioned medium), BCCM (bovine cell conditioned medium), XIAP (X-linked inhibitor of
apoptosis protein), Smac (small mitochondria-derived activator of caspases), Diablo (direct IAP binding protein with low pI).
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Page 13 of 15of caspase-9 actions (Figure 6). Pro-caspase-9 and
APAF-1 form the ‘apoptosome’, a process mediated by
cytochrome c (C*, Figure 6) which is translocated from
the mitochondria. Formation of the apoptosome leads to
activation of caspase-3 and this step was inhibited by
NCCM (but not BCCM) in our IL-1b-a n dF a s L - t r e a t e d
NP cells. Our results are in keeping with the results of
others [9] showing that Bid, cytochrome-c, and activated
caspases-9 and -3 were robustly detected in all herniated
NP tissues examined (n = 32 cases) while little caspase-8
activity was detected. We recognize that apoptotic sig-
naling downstream of activated caspase-9 involves com-
plex interactions between such mediators of Smac/
Diablo and X-linked inhibitor of apoptosis proteins
(XIAP) that control activated caspase-3 signaling [37].
Components within NCCM may function in similar
ways to these naturally occurring inhibitors of apoptosis
although at present these mechanisms are unknown.
S t u d i e st oe x a m i n et h er o l ep l a y e db yN C C Mf a c t o r si n
reducing activated caspase-3 are ongoing.
Study limitations
Gene Expression
’Fold changes’ in gene expression are dependent upon
threshold calculations (ΔCt and ΔΔCt), therefore very
small denominators could over-estimate such fold
changes and must be interpreted with some caution.
However, we observed similar gene expression changes
for these two genes in entirely separate experiments
using cells pooled together from completely independent
animals. Therefore, when taken together with our pre-
vious findings that NCCM up-regulates NP aggrecan
expression, it does appear that there is a strong protec-
tion of aggrecan and link protein conferred by the com-
ponents of NCCM.
NCCM ‘dose’
We developed NCCM from two entirely separate pools
of non-chondrodystrophic canine notochordal cell
sources. In the first set of serum-free NCCM we used
1.5 × 10
6 c e l l s / m La l g i n a t ea n di nt h es e c o n dw eu s e d
half that concentration. We have determined through
past experience that a dose-dependent relationship
exists between the concentration of notochordal cells
and the biological effect of NCCM [4] and have consid-
erable experience generating NCCM. In the second set
of 2% NCCM experiments where we developed NCCM
from 0.75 × 10
6 cells/mL alginate we reduced the
volume of medium used to generate the NCCM by 50%
from 6 to 3 mL thereby increasing the ‘concentration’ of
the NCCM in an attempt to mitigate against the lower
notochordal cell harvest from those animals. We
observed similar gene expression effects upon the bovine
NP cells (data not shown) and observed suppressed acti-
vated caspase-3 activity verifying that just as with the
serum-free NCCM, the 2% NCCM retained its anti-
apoptotic activity.
Conclusions
We have demonstrated in this study that NCCM protects
against NP apoptosis via suppression of activated cas-
pase-9 and -3/7. Possible mechanisms include stabiliza-
tion of the mitochondrial membrane via inhibition of
Bcl-2 activity, Bid activation or through the P53 growth
factor-related pathway. It may be that components of
NCCM suppress the formation of the apoptosome and in
so doing suppress the formation of activated caspase-3
thereby preventing apoptotic cell death. The novel find-
ing of the activation of the Ank gene by NCCM under
degenerative/death-inducing conditions suggests a possi-
ble role for this gene in the maintenance of NP cell phe-
notype. These areas are under examination by our group.
The results of the present study provide evidence in
vitro that notochordal cell-secreted soluble factors pro-
vide essential molecular signals that mediate apoptosis
and degradation of NP cells induced by IL-1b+Fas-L.
Harnessing the regenerative capacity of these cells and
the important factors they secrete may lay the corner-
stone of biological therapy for the treatment of degen-
erative disc disease.
Additional material
Additional file 1: Figure S1: Activated caspase-3 activity in NP cells
treated with IL-1b + FasL for 24 and 48 hours (expressed relative to
untreated cells). There is a clear and significant induction of cleaved/
activated caspase-3 in the 48-hour treatment group verifying the
induction of apoptosis. This is the same trend observed with fluorescent
activated cell sorting analysis using Annexin V and Propidium Iodide. (Y
axis refers to luminescence units/hour).
Abbreviations
ADAMTS: a disintegrin and metalloproteinase with thrombospondin motifs;
ADMEM/F-12: Advanced Dulbecco’s Modified Eagle Medium with F-12
supplement; AFC: 7-amino-4-trifluoromethyl coumarin; ANKH: a
transmembrane protein encoded by the ANKH gene that controls
pyrophosphate levels in cells and tissues of joints although it is found in
other tissues. A mutation at the (ank) locus results in generalized,
progressive arthritis and joint destruction/ankylosis; AV: annexin-V; BCCM:
bovine NP cells; Bcl-2: B-cell lymphoma 2; Bid: BH3 interacting domain death
agonist; CD: chondrodystrophic canine; CD95: cluster of differentiation 95
(also known as Fas-receptor); DDD: degenerative disc disease; DMEM:
Dulbecco’s modified Eagle’s medium; ECM: extracellular matrix; FasL: soluble
Fas receptor ligand; Fas Receptor: receptor for Fas-ligand also known as
CD95; FBS: fetal bovine serum; IL-1ß: interleukin-1 beta; IL-6: interleukin-6;
IVD: intervertebral disc; MMP: matrix metalloproteinase; NCCM: notochordal
cell conditioned medium; NCD: non-chondrodystrophic canine; NP: nucleus
pulposus; PBS: phosphate-buffered saline; PI: propridium iodide; PPi:
inorganic pyrophosphate; PS: penicillin/streptomycin; RT-PCR: real time
polymerase chain reaction; TIMPS: tissue inhibitors of metalloproteinases.
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